INTAL NEBULISER SOLUTION Nebulization
Sodium Cromoglycate (Cromoglicic acid)
20mg/2ml
Fisons Pharmaceuticals
| Pack size | 2ml Ampoule x 48 |
|---|---|
| Dispensing mode | POM |
| Source | UK |
| Agent | AL RAZI PHARMACY |
| Retail Price | 59.50 AED |
Available as:
Indications
INTAL NEBULISER SOLUTION Nebulization is used for:
Asthma, Asthma propylaxis
Adult Dose
Adults:
Inhalation
Asthma prophylaxis As dry powd/ nebulising soln: 20 mg 4 times/day
As aerosol:10 mg 4 times/day, up to 6-8 times/day if needed, reduced to 5 mg 4 times/day once asthma has stabilised.
Additional doses may be taken before exercise.
Child Dose
Renal Dose
Administration
Contra Indications
Hypersensitivity.
Precautions
Lactation, cardiac arrhythmias, hepatic or renal dysfunction.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Sodium Cromoglycate (Cromoglicic acid) :
Nausea, headache, dizziness, unpleasant taste, joint pain and swelling, skin rashes, aggravation of asthma, pulmonary infiltrates with eosinophilia, urticaria. Bronchospasm, wheezing, cough, nasal congestion and throat irritation following inhalation of dry powder.
Mechanism of Action
Sodium Cromoglycate inhibits degranulation of mast cells and therefore suppresses the release of histamine, leukotrienes and slow-reacting substance of anaphylaxis.
Note
INTAL NEBULISER SOLUTION 20mg/2ml Nebulization manufactured by Fisons Pharmaceuticals. Its generic name is Sodium Cromoglycate (Cromoglicic acid). INTAL NEBULISER SOLUTION is availble in United Arab Emirates.
Farmaco UAE drug index information on INTAL NEBULISER SOLUTION Nebulization is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.